Randomized phase I trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma: Clinical and translational results. This is an ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results